Enterprise Value
-1.102M
Cash
3.001M
Avg Qtr Burn
-2.27M
Short % of Float
11.01%
Insider Ownership
18.88%
Institutional Own.
31.33%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ATR-12 Details Netherton syndrome | Phase 1b Data readout | |
ATR-04 Details Skin disease/disorder | Phase 1 Initiation |